Company Overview of Lux Capital Management
Lux Capital Management is a venture capital firm specializing in investments in seed, early stage investments, special situations, and corporate spinouts. The firm primarily invests in energy, life sciences, biopharmaceutical, healthcare, and technology. It also seeks to invest in emerging technologies with a focus on advanced materials, drug delivery, therapeutics, mobile health, services, novel materials, energy, energy technology, wireless, semiconductors, nanotechnology, alternative energy technologies, and biotechnology sectors. It targets investing from $0.1 million in companies. The firm seeks to be a first institutional investor in its portfolio companies. It also provides follow on ...
295 Madison Avenue
New York, NY 10017
Founded in 2000
Key Executives for Lux Capital Management
Co-Founder and Managing Partner
Vice President and Director of Operations
Compensation as of Fiscal Year 2012.
Lux Capital Management Key Developments
Lux Capital Management Adds Bilal Zuberi as Partner at its Palo Alto Office
May 9 13
Lux Capital Management announced that Bilal Zuberi was joining the firm as a Partner in its Palo Alto office. Bilal joins from General Catalyst Partners, where he was a Principal in the firm's Boston office, making investments in transformative technology companies including Gridco Systems, Arc Energy, SunBorne, CleaResult, SynapDx, and CyPhy Works. He will focus on identifying and leading early-stage investments across the Energy, Technology and Healthcare sectors, and will also work with existing Lux portfolio companies. Zuberi spent the last 10 years as an entrepreneur and investor in early-stage technology companies. Prior to joining General Catalyst, Bilal was a co-founder of GEO2 Technologies.
Lux Capital Management Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-06-2013 03:50 PM
Jan 4 13
Lux Capital Management Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-06-2013 03:50 PM. Venue: Four Seasons Hotel, San Francisco, California, United States. Speakers: Jeffrey B. Kindler, Venture Partner.
Lux Capital Management Appoints Jeff Kindler as Venture Partner
Aug 8 12
Lux Capital Management announced that former Pfizer Chairman and CEO Jeff Kindler joined the firm as a Venture Partner. Kindler will help identify new healthcare investment opportunities and work with Lux portfolio companies. He joins other recent Venture Partner additions Jim Woolsey and Richard Foster in sourcing breakthrough ventures and brilliant entrepreneurs. In addition to his role as Venture Partner at Lux Capital, Jeff Kindler is senior advisor to Paragon Pharmaceuticals. He also serves on the boards of AgaMatrix; Intrexon; Sheridan Healthcare, hospitals, and outpatient centers, Tufts University; and the Manhattan Theatre Club. He is a member of President Obama's Management Advisory Board and a director at Starboard Capital Partners.
Similar Private Companies By Industry
Recent Private Companies Transactions